These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7897693)

  • 1. Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics.
    Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
    J Toxicol Environ Health; 1995 Mar; 44(3):301-17. PubMed ID: 7897693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
    Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
    Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
    Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule-controlled operant behavior of rats following oral administration of perchloroethylene: time course and relationship to blood and brain solvent levels.
    Warren DA; Reigle TG; Muralidhara S; Dallas CE
    J Toxicol Environ Health; 1996 Mar; 47(4):345-62. PubMed ID: 8600288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a physiologically based pharmacokinetic model for perchloroethylene using tissue concentration-time data.
    Dallas CE; Chen XM; O'Barr K; Muralidhara S; Varkonyi P; Bruckner JV
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):50-9. PubMed ID: 8079354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model.
    Byczkowski JZ; Kinkead ER; Leahy HF; Randall GM; Fisher JW
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):228-36. PubMed ID: 8171430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene.
    Keys DA; Bruckner JV; Muralidhara S; Fisher JW
    Toxicol Sci; 2003 Nov; 76(1):35-50. PubMed ID: 12915716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute perchloroethylene exposure alters rat visual-evoked potentials in relation to brain concentrations.
    Boyes WK; Bercegeay M; Oshiro WM; Krantz QT; Kenyon EM; Bushnell PJ; Benignus VA
    Toxicol Sci; 2009 Mar; 108(1):159-72. PubMed ID: 19098276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.
    Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake, distribution, and elimination of carbon tetrachloride in rat tissues following inhalation and ingestion exposures.
    Sanzgiri UY; Srivatsan V; Muralidhara S; Dallas CE; Bruckner JV
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):120-9. PubMed ID: 9073600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian analysis of a physiologically based pharmacokinetic model for perchloroethylene in humans.
    Qiu J; Chien YC; Bruckner JV; Fisher JW
    J Toxicol Environ Health A; 2010; 73(1):74-91. PubMed ID: 19953421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model.
    Yamazaki S; Skaptason J; Romero D; Vekich S; Jones HM; Tan W; Wilner KD; Koudriakova T
    Drug Metab Dispos; 2011 Mar; 39(3):383-93. PubMed ID: 21098644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based pharmacokinetic rat model for methyl tertiary-butyl ether; comparison of selected dose metrics following various MTBE exposure scenarios used for toxicity and carcinogenicity evaluation.
    Borghoff SJ; Parkinson H; Leavens TL
    Toxicology; 2010 Sep; 275(1-3):79-91. PubMed ID: 20561556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
    Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
    J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis.
    Himmelstein MW; Carpenter SC; Evans MV; Hinderliter PM; Kenyon EM
    Toxicol Sci; 2004 May; 79(1):28-37. PubMed ID: 14976335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE).
    Gearhart JM; Mahle DA; Greene RJ; Seckel CS; Flemming CD; Fisher JW; Clewell HJ
    Toxicol Lett; 1993 May; 68(1-2):131-44. PubMed ID: 8516760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses.
    Meno-Tetang GM; Li H; Mis S; Pyszczynski N; Heining P; Lowe P; Jusko WJ
    Drug Metab Dispos; 2006 Sep; 34(9):1480-7. PubMed ID: 16751263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.